| Molecular Formula | C24H28Cl2N2O4 |
| Molar Mass | 479.4 |
| Solubility | DMSO: ≥ 42 mg/mL |
| Appearance | powder |
| Color | white to tan |
| Storage Condition | Sealed in dry,Room Temperature |
| In vitro study | SBE 13 decreases cell proliferation in various cancer cell lines, and causes a G2/M arrest followed by apoptosis. In primary cells, SBE 13 does not impair cell cycle and thus proliferation of primary cells. SBE13 in combination with Enzastaurin displays a synergistic reduction of cell proliferation and enhanced apoptosis induction in HCT116(p53-/-) cells. |
| Hazard Symbols | Xn - Harmful![]() |
| Risk Codes | 22 - Harmful if swallowed |
| WGK Germany | 3 |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 2.086 ml | 10.43 ml | 20.86 ml |
| 5 mM | 0.417 ml | 2.086 ml | 4.172 ml |
| 10 mM | 0.209 ml | 1.043 ml | 2.086 ml |
| 5 mM | 0.042 ml | 0.209 ml | 0.417 ml |